Alpha-lipoic acid supplementation and diabetes

Nutrition Reviews

Volumn 66, Issue 11, 2008, Pages 646-657

  Singh, Uma ^a   Jialal, Ishwarlal ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Laboratory for Atherosclerosis and Metabolic Research   (United States)

Author keywords

Diabetes; Diabetic neuropathy; Dosage; Lipoic acid; Oxidative stress

Indexed keywords

ASCORBIC ACID; FREE RADICAL; GLUTATHIONE; METAL CHELATE; METFORMIN; MITOCHONDRIAL ENZYME; PLACEBO; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; TRACE ELEMENT; UBIDECARENONE;

ABDOMINAL PAIN; ANAPHYLAXIS; ANTIOXIDANT ACTIVITY; AUTONOMIC NEUROPATHY; BIOENERGY; CARDIOVASCULAR RISK; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIARRHEA; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; FATIGUE; GASTROINTESTINAL SYMPTOM; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; HEAVY METAL POISONING; HUMAN; INSOMNIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; LARYNX SPASM; MONOTHERAPY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; POLYNEUROPATHY; PRURITUS; RASH; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN ALLERGY; URINE MALODOR; URINE ODOR; VERTIGO; VOMITING;

AGING; ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; DIABETES MELLITUS; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; FREE RADICAL SCAVENGERS; HEAVY METAL POISONING, NERVOUS SYSTEM; HUMANS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; THIOCTIC ACID;

EID: 54949103935     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00118.x     Document Type: Review

References (65)

1. Reed LJ. A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes. J Biol Chem. 2001 276 : 38329 38336.
2. Carreau JP. Biosynthesis of lipoic acid via unsaturated fatty acids. Methods Enzymol. 1979 62 : 152 158.
3. Smith AR, Shenvi SV, Widlansky M, et al. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem. 2004 11 : 1135 1146.
4. Kramer K, Packer L. R-alpha-lipoic acid. In : Kramer K, Hoppe P, Packer L, eds. Nutraceuticals in Health and Disease Prevention. New York : Marcel Dekker, Inc 2001 : 129 164.
5. Estrada DE, Ewart HS, Tsakiridis T, et al. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes. 1996 45 : 1798 1804.
6. Khanna S, Roy S, Packer L, et al. Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of alpha-lipoic acid. Am J Physiol. 1999 276 : R1327 R1333.
7. Pick U, Haramaki N, Constantinescu A, et al. Glutathione reductase and lipoamide dehydrogenase have opposite stereospecificities for alpha-lipoic acid enantiomers. Biochem Biophys Res Commun. 1995 206 : 724 730.
8. Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med. 1995 19 : 227 250.
9. Marangon K, Devaraj S, Tirosh O, et al. Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med. 1999 27 : 1114 1121.
10. Jones W, Li X, Qu ZC, et al. Uptake, recycling, and antioxidant actions of alpha-lipoic acid in endothelial cells. Free Radic Biol Med. 2002 33 : 83 93.
11. Kozlov AV, Gille L, Staniek K, et al. Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone. Arch Biochem Biophys. 1999 363 : 148 154.
12. Suh JH, Shenvi SV, Dixon BM, et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A. 2004 101 : 3381 3386.
13. Bast A, Haenen GR. Lipoic acid: a multifunctional antioxidant. Biofactors. 2003 17 : 207 213.
14. Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997 29 : 315 331.
15. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005 12 : 1161 1208.
16. Doraiswamy PM, Finefrock AE. Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol. 2004 3 : 431 434.
17. Suh JH, Zhu BZ, deSzoeke E, et al. Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes. Redox Rep. 2004 9 : 57 61.
18. Suh JH, Moreau R, Heath SH, Hagen TM. Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep. 2005 10 : 52 60.
19. Hendler SS, Rorvik DR, eds. PDR for Nutritional Supplements. Montvale : Medical Economics Company, Inc 2001.
20. Gleiter CH, Schug BS, Hermann R, et al. Influence of food intake on the bioavailability of thioctic acid enantiomers. Eur J Clin Pharmacol. 1996 50 : 513 514.
21. Hermann R, Niebch G, Borbe HO, et al. Enantioselective pharmacokinetics and bioavailability of different racemic alpha-lipoic acid formulations in healthy volunteers. Eur J Pharm Sci. 1996 4 : 167 174.
22. Teichert J, Preiss R. HPLC-methods for determination of lipoic acid and its reduced form in human plasma. Int J Clin Pharmacol Ther Toxicol. 1992 30 : 511 512.
23. Ross SM. Clinical applications of lipoic acid in type II diabetes mellitus. Holist Nurs Pract. 2006 20 : 305 306.
24. Faust A, Burkart V, Ulrich H, et al. Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice. Int J Immunopharmacol. 1994 16 : 61 66.
25. Burkart V, Koike T, Brenner HH, et al. Dihydrolipoic acid protects pancreatic islet cells from inflammatory attack. Agents Actions. 1993 38 : 60 65.
26. Haugaard N, Haugaard ES. Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochim Biophys Acta. 1970 222 : 583 586.
27. Singh HP, Bowman RH. Effect of DL-alpha-lipoic acid on the citrate concentration and phosphofructokinase activity of perfused hearts from normal and diabetic rats. Biochem Biophys Res Commun. 1970 41 : 555 561.
28. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 2008 PMID: 18640680 Epub ahead of print V, Nourooz-Zadeh J, Wolff SP, et al. alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med. 1999 26 : 1495 1500.
29. Hofmann MA, Schiekofer S, Kanitz M, et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care. 1998 21 : 1310 1316.
30. Förstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 2008 5 : 338 349.
31. Morcos M, Borcea V, Isermann B, et al. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract. 2001 52 : 175 183.
32. Androne L, Gavan NA, Veresiu IA, et al. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy. In Vivo. 2000 14 : 327 330.
33. Konrad D. Utilization of the insulin-signaling network in the metabolic actions of alpha-lipoic acid-reduction or oxidation? Antioxid Redox Signal. 2005 7 : 1032 1039.
34. Yaworsky K, Somwar R, Ramlal T, et al. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia. 2000 43 : 294 303.
35. Jacob S, Henriksen EJ, Schiemann AL, et al. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung. 1995 45 : 872 874.
36. Jacob S, Henriksen EJ, Tritschler HJ, et al. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes. 1996 104 : 284 288.
37. Jacob S, Rett K, Henriksen EJ, et al. Thioctic acid effects on insulin sensitivity and glucose-metabolism. Biofactors. 1999 10 : 169 174.
38. Evans JL, Heymann CJ, Goldfine ID, et al. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid. Endocr Pract. 2002 8 : 29 35.
39. Konrad T, Vicini P, Kusterer K, et al. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care. 1999 22 : 280 287.
40. Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens). 2006 5 : 251 258.
41. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005 109 : 143 159.
42. Gokce N, Keaney JF Jr., Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003 41 : 1769 1775.
43. Heitzer T, Finckh B, Albers S, et al. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med. 2001 31 : 53 61.
44. Sola S, Mir MQ, Cheema FA, et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation. 2005 111 : 343 348.
45. Haak E, Usadel KH, Kusterer K, et al. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes. 2000 108 : 168 174.
46. Jin HY, Joung SJ, Park JH, et al. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy. Diabet Med. 2007 24 : 1034 1038.
47. Meijer JW, Lange F, Links TP, et al. Muscle fiber conduction abnormalities in early diabetic polyneuropathy. Clin Neurophysiol. 2008 119 : 1379 1384.
48. Coppey LJ, Gellett JS, Davidson EP, et al. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes. 2001 50 : 1927 1937.
49. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care. 1999 22 : 1296 1301.
50. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995 38 : 1425 1433.
51. Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res. 1999 31 : 171 179.
52. Ruhnau KJ, Meissner HP, Finn JR, et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med. 1999 16 : 1040 1043.
53. Foster TS. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ. 2007 33 : 111 117.
54. Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003 26 : 770 776.
55. Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006 29 : 2365 2370.
56. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol. 2004 3 : 173 189.
57. Ziegler D, Schatz H, Conrad F, et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997 20 : 369 373.
58. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004 21 : 114 121.
59. Tang J, Wingerchuk DM, Crum BA, et al. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neurologist. 2007 13 : 164 167.
60. Tankova T, Koev D, Dakovska L. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study). Rom J Intern Med. 2004 42 : 457 464.
61. Yadav V, Marracci G, Lovera J, et al. Lipoic acid in multiple sclerosis: a pilot study. Mult Scler. 2005 11 : 159 165.
62. Bernkop-Schnürch A, Reich-Rohrwig E, Marschütz M, et al. Development of a sustained release dosage form for alpha-lipoic acid. II. Evaluation in human volunteers. Drug Dev Ind Pharm. 2004 30 : 35 42.
63. Hermann R, Wildgrube HJ, Ruus P, et al. Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers. Eur J Pharm Sci. 1998 6 : 27 37.
64. Prasad PD, Ramamoorthy S, Leibach FH, et al. Characterization of a sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin and lipoate in human placental choriocarcinoma cells. Placenta. 1997 18 : 527 533.
65. Zempleni J, Mock DM. Biotin biochemistry and human requirements. J Nutr Biochem. 1999 10 : 128 138.